Institute for Drug Development Cancer Therapy and Research Center

San Antonio, Texas 78229

0 studies enrolling now · 2 studies all time

What they study most

Advanced Non Small Cell Lung Cancer, Failed Prior Chemotherapy, Sarcoma, Soft Tissue

Studies at this site

• Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer — Completed
• Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma — Paused